x
SIGN UP
About Us
Back
Overview
Leadership Team
Board of Directors
Scientific Advisors
Partners
Careers
Science & Technology
Back
Protein Misfolding
See-TX™ Platform
STARs
Publications
Pipeline
Back
Investors & Media
Back
Overview
News and Events
Stock Information
SEC Filings
Corporate Governance
Investor Resources
Contact Us
Back
Newsroom
In the news
BioTalk
BioTalk with Rich Bendis
RareDaily
Gain Therapeutics Raises $40M in IPO to Advance Rare Disease Pipeline
Nasdaq
Lysosomal storage disorder biotech Gain Therapeutics prices IPO at $11 midpoint
pm360
Gain Therapeutics Strengthens Leadership Team with the Appointment of Four Industry Leaders to Its Board of Directors
Pharmaceutical Technology
Treating lysosomal storage disorders: Gain and Sumitomo Dainippon enter partnership
BioWorld
Gain Therapeutics Inc. signs a collaboration with Sumitomo Dainippon Pharma Co. Ltd.
BioSpace
Gain Therapeutics, Inc. Announces Close of $10 Million Series B Financing
Proactive
Gain Therapeutics finalizing animal proof-of-concept study in Parkinson's Disease
